The Australian Nuclear Science and Technology Organization (ANSTO)’s new $168 million nuclear medicine facility halted all production after two employees were exposed to an unsafe dose of radiation on Friday, June 21, according to a statement from the organization.

Intravenous (IV) administration of technetium-99m (99mTc) was shown to be a safe, noninvasive way to observe rheumatoid arthritis disease activity, according to a study presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Anaheim, Calif.

University of North Carolina-Chapel Hill researchers have developed a new method for creating radiotracers used in PET imaging. The technique may improve imaging of diseases such as cancer, according to the study published in Science.

Immuno-PET offers a more efficient diagnosis of inflammation in inflammatory bowel disease (IBD) compared to traditional invasive methods, according to a new study published in the June issue of the Journal of Nuclear Medicine.

Using an automated technique to quantify amyloid plaque on PET scans in a patient’s native space can improve the detection of brain amyloid accumulation compared to traditional methods, according to a recent study published in the Journal of Nuclear Medicine.

Until now, the $168 million facility was producing limited amounts of Mo-99, a radioisotope used in approximately 85% of all Australian nuclear medicine procedures such as SPECT scans.

A team of German researchers has found a new class of radiopharmaceuticals capable of identifying 28 types of malignant tumors, imaging them with high uptake and image contrast.

The U.S. Pharmacopeia (USP) recently published a new chapter outlining minimum standards for preparing, compounding, dispensing and packaging sterile and non-sterile radiopharmaceuticals that are part of state-licensed activities.